Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details
 
Open AccessHighly AccessResearch

Early right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: a Doppler Tissue and Speckle Tracking echocardiography study

Sebastian Schattke1* email, Fabian Knebel1* email, Andrea Grohmann1 email, Henryk Dreger1 email, Friederike Kmezik1 email, Gabriela Riemekasten2 email, Gert Baumann1 email and Adrian C Borges1 email

Universitätsmedizin Berlin, Medical Clinic for Cardiology and Angiology, Charité Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany

Universitätsmedizin Berlin, Medical Clinic for Rheumatology, Charité Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany

author email corresponding author email* Contributed equally

Cardiovascular Ultrasound 2010, 8:3doi:10.1186/1476-7120-8-3

Published: 22 January 2010

Abstract

Background

Isovolumetric acceleration (IVA) is a novel tissue Doppler parameter for the assessment of systolic function. The aim of this study was to evaluate IVA as an early parameter for the detection of right ventricular (RV) systolic dysfunction in patients with systemic sclerosis (SSc) without pulmonary hypertension.

Methods

22 patients and 22 gender- and age-matched healthy subjects underwent standard echocardiography with tissue Doppler imaging (TDI) and speckle tracking strain to assess RV function.

Results

Tricuspid annular plane systolic excursion (TAPSE) (23.2 ± 4.1 mm vs. 26.5 ± 2.9 mm, p < 0.006), peak myocardial systolic velocity (Sm) (11.6 ± 2.3 cm/s vs. 13.9 ± 2.7 cm/s, p = 0.005), isovolumetric contraction velocity (IVV) (10.3 ± 3 cm/s vs. 14.8 ± 3 cm/s, p < 0.001) and IVA (2.3 ± 0.4 m/s2 vs. 4.1 ± 0.8 m/s2, p < 0.001) were significant lower in the patient group. IVA was the best parameter to predict early systolic dysfunction with an area under the curve of 0.988.

Conclusion

IVA is a useful tool with high-predictive power to detect early right ventricular systolic impairment in patients with SSc and without pulmonary hypertension.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.